CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue:
Premium revenue	$ 1,680,450	$ 860,631
Direct contracting revenue	182,797	0
Service revenue	$ 12,428	$ 8,438
Revenue, Product and Service [Extensible Enumeration]	Service [Member]	Service [Member]
Investment income (loss)	$ (40,100)	$ 5,489
Total revenue	1,835,575	874,558
Operating expenses:
Medical costs	1,580,596	684,570
Operating costs	418,918	208,240
Depreciation and amortization	13,041	4,581
Total operating expenses	2,012,555	897,391
Operating loss	(176,980)	(22,833)
Interest expense	1,193	546
Other income	(784)	0
Loss before income taxes	(177,389)	(23,379)
Income tax expense	3,240	1,166
Net loss	(180,629)	(24,545)
Net earnings attributable to noncontrolling interests	(14,605)	(617)
Series A preferred stock dividend accrued	(8,938)	0
Net loss attributable to Bright Health Group, Inc. common shareholders	$ (204,172)	$ (25,162)
Basic loss per share attributable to Bright Health Groups, Inc. common shareholders (in dollars per share)	$ (0.32)	$ (0.18)
Diluted loss per share attributable to Bright Health Groups, Inc. common shareholders (in dollars per share)	$ (0.32)	$ (0.18)
Basic weighted-average common shares outstanding (in shares)	628,765	140,175
Diluted weighted-average common shares outstanding (in shares)	628,765	140,175